Search
Patexia Research
Case number 3:18-cv-01394

H. LUNDBECK A/S et al v. SANDOZ INC. et al > Summary

Court Case Number 3:18-cv-01394

Filing Date Jan 31, 2018

Termination Date May 1, 2018

Court New Jersey District Court

Status Dismissed - Voluntarily

JudgesFreda L. Wolfson, Lois H. Goodman

Plaintiff

3

Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals North America

H. Lundbeck A/S

Defendant

2

Sandoz

LEK PHARMACEUTICALS D.D. (Sandoz)

Cause

35:271 Patent Infringement

Related Patents

Doc No Title Issue date
09227946 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment Jan 5, 2016
08969355 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment Mar 3, 2015
08722684 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment May 13, 2014
Menu